Paul Hergenrother has won the Sosnovsky Award for Cancer Research, one of the National Awards of the American Chemical Society.

The award recognizes his long-standing leadership in the development of anti-cancer drugs, and especially the discovery of the first procaspase-activating compound, PAC-1. His work takes cancer treatment into the realm of personalized medicine.